You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
|
|---|---|
| Published in |
Lancet Oncology, April 2019
|
| DOI | 10.1016/s1470-2045(19)30027-0 |
| Pubmed ID | |
| Authors |
Cathy Eng, Tae Won Kim, Johanna Bendell, Guillem Argilés, Niall C Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark Kozloff, Neil H Segal, Alberto Sobrero, Yibing Yan, Ilsung Chang, Anne Uyei, Louise Roberts, Fortunato Ciardiello, IMblaze370 Investigators, JB Ahn, J Asselah, S Badarinath, S Baijal, S Begbie, S Berry, JL Canon, RG Carbone, A Cervantes, YJ Cha, K Chang, A Chaudhry, E Chmielowska, SH Cho, D Chu, F Couture, J Cultrera, D Cunningham, E Van Cutsem, PJ Cuyle, J Davies, S Dowden, M Dvorkin, V Ganju, RV Garcia, R Kerr, TY Kim, K King, J Kortmansky, M Kozloff, KO Lam, J Lee, AS Lee, B Lesperance, G Luppi, B Ma, E Maiello, R Mandanas, J Marshall, G Marx, S Mullamitha, M Nechaeva, JO Park, N Pavlakis, CG Ponce, P Potemski, S Raouf, J Reeves, N Segal, S Siena, A Smolin, JO Streb, A Strickland, E Szutowicz-Zielinska, JM Tabernero, B Tan, JS Valera, M Van den Eynde, P Vergauwe, M Vickers, M Womack, M Wroblewska, R Young |
X Demographics
The data shown below were collected from the profiles of 85 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 21% |
| Spain | 16 | 19% |
| Japan | 5 | 6% |
| Brazil | 4 | 5% |
| United Kingdom | 2 | 2% |
| France | 1 | 1% |
| Ecuador | 1 | 1% |
| Italy | 1 | 1% |
| Australia | 1 | 1% |
| Other | 10 | 12% |
| Unknown | 26 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 53 | 62% |
| Practitioners (doctors, other healthcare professionals) | 22 | 26% |
| Scientists | 7 | 8% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 286 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 286 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 47 | 16% |
| Student > Ph. D. Student | 24 | 8% |
| Other | 22 | 8% |
| Student > Bachelor | 18 | 6% |
| Student > Master | 16 | 6% |
| Other | 59 | 21% |
| Unknown | 100 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 78 | 27% |
| Biochemistry, Genetics and Molecular Biology | 28 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 5% |
| Nursing and Health Professions | 10 | 3% |
| Immunology and Microbiology | 8 | 3% |
| Other | 34 | 12% |
| Unknown | 114 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 91. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2021.
All research outputs
#467,961
of 25,385,509 outputs
Outputs from Lancet Oncology
#599
of 6,885 outputs
Outputs of similar age
#10,132
of 347,757 outputs
Outputs of similar age from Lancet Oncology
#16
of 129 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,885 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,757 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 129 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.